{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:40:23Z","timestamp":1787992823227,"version":"build-2784847793"},"reference-count":214,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-9\/2021-14\/ 200017"],"award-info":[{"award-number":["451-03-9\/2021-14\/ 200017"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004052","name":"King Abdullah University of Science and Technology","doi-asserted-by":"publisher","award":["BAS\/1\/1624-01-01, FCC\/1\/1976-20-01, FCC\/1\/1976-26-01, OSR 4129"],"award-info":[{"award-number":["BAS\/1\/1624-01-01, FCC\/1\/1976-20-01, FCC\/1\/1976-26-01, OSR 4129"]}],"id":[{"id":"10.13039\/501100004052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetes mellitus (DM) is on the rise, necessitating the development of novel therapeutic and preventive strategies to mitigate the disease\u2019s debilitating effects. Diabetic cardiomyopathy (DCMP) is among the leading causes of morbidity and mortality in diabetic patients globally. DCMP manifests as cardiomyocyte hypertrophy, apoptosis, and myocardial interstitial fibrosis before progressing to heart failure. Evidence suggests that non-coding RNAs, such as long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), regulate diabetic cardiomyopathy-related processes such as insulin resistance, cardiomyocyte apoptosis and inflammation, emphasizing their heart-protective effects. This paper reviewed the literature data from animal and human studies on the non-trivial roles of miRNAs and lncRNAs in the context of DCMP in diabetes and demonstrated their future potential in DCMP treatment in diabetic patients.<\/jats:p>","DOI":"10.3389\/fendo.2023.1124613","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T06:43:30Z","timestamp":1678085010000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs"],"prefix":"10.3389","volume":"14","author":[{"given":"Mirjana T.","family":"Macvanin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Gluvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Radovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magbubah","family":"Essack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma R.","family":"Isenovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.117.311586","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: Current and future therapies. beyond glycemic control","volume":"9","author":"Borghetti","year":"2018","journal-title":"Front Physiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the heart failure association of the European society of cardiology","volume":"20","author":"Seferovi\u0107","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.907757","article-title":"Signaling pathways related to oxidative stress in diabetic cardiomyopathy","volume":"13","author":"Peng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: Outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejcnurse.2005.03.010","article-title":"Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure","volume":"4","author":"Zambroski","year":"2005","journal-title":"Eur J Cardiovasc Nurs"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2012.12.008","article-title":"Diabetes and cardiovascular disease: Original insights from the framingham heart study","volume":"8","author":"Qazi","year":"2013","journal-title":"Glob Heart"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-017-0219-z","article-title":"Can the onset of heart failure be delayed by treating diabetic cardiomyopathy","volume":"9","author":"Marcinkiewicz","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310342","article-title":"Diabetic cardiomyopathy","author":"Lee","year":"2019","journal-title":". Heart"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic cardiomyopathy: Definition, diagnosis, and therapeutic implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Fail Clin"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: A scientific statement from the American heart association and the heart failure society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovascular Diabetology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy - a comprehensive updated review","volume":"62","author":"Murtaza","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nature Reviews Cardiology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00002","article-title":"Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links","volume":"9","author":"De Rosa","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12872-018-0939-5","article-title":"Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy","volume":"18","author":"Pant","year":"2018","journal-title":"BMC Cardiovascular Disorders"},{"key":"B23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","article-title":"MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics","volume":"20","author":"Jakubik","year":"2021","journal-title":"Cardiovascular Diabetology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2012.11.015","article-title":"miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300","volume":"319","author":"Duan","year":"2013","journal-title":"Exp Cell Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12218","article-title":"Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes","volume":"18","author":"Chen","year":"2014","journal-title":"J Cell Mol Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2015.06.003","article-title":"Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice","volume":"24","author":"Yu","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.112.267732","article-title":"Nuclear miRNA regulates the mitochondrial genome in the heart","volume":"110","author":"Das","year":"2012","journal-title":"Circ Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.07.105","article-title":"MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes","volume":"425","author":"Chavali","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060545","article-title":"MicroRNA-301a mediated regulation of Kv4.2 in diabetes: identification of key modulators","volume":"8","author":"Panguluri","year":"2013","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2011.01.001","article-title":"Long noncoding RNAs in cell biology","volume":"22","author":"Clark","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks296","article-title":"Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs","volume":"40","author":"Moran","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.116.302521","article-title":"Long noncoding RNAs in cardiovascular diseases","volume":"116","author":"Uchida","year":"2015","journal-title":"Circ Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7315","article-title":"Long noncoding RNAs in diabetes and diabetic complications","volume":"29","author":"Leung","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3171-6","article-title":"). molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/656795","article-title":"Updating experimental models of diabetic cardiomyopathy","volume":"2015","author":"Fuentes-Antr\u00e1s","year":"2015","journal-title":"J Diabetes Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.208","article-title":"Diabetic cardiomyopathy: where we are and where we are going","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J Intern Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1042\/cs20160491","article-title":"Are targeted therapies for diabetic cardiomyopathy on the horizon","volume":"131","author":"Tate","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.9.2709","article-title":"Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase c beta2 activation and diabetes","volume":"51","author":"Way","year":"2002","journal-title":"Diabetes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1163","article-title":"Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2017.3779","article-title":"Endothelial-to-Mesenchymal transition: A potential mechanism for atherosclerosis plaque progression and destabilization","volume":"36","author":"Li","year":"2017","journal-title":"DNA Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2020.08.015","article-title":"Disruption of energy utilization in diabetic cardiomyopathy; a mini review","volume":"54","author":"Nirengi","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.3390\/ijms23147863","article-title":"The role of mitochondrial abnormalities in diabetic cardiomyopathy","volume":"23","author":"Dabravolski","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/ijms17122136","article-title":"Diabetic cardiomyopathy: Does the type of diabetes matter","volume":"17","author":"H\u00f6lscher","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10200-y","article-title":"Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants","author":"Prandi","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population","volume":"101","author":"Eguchi","year":"2008","journal-title":"Am J Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2147\/vhrm.s11681","article-title":"Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies","volume":"6","author":"Voulgari","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ar.22646","article-title":"Diabetic basement membrane thickening does not occur in myocardial capillaries of transgenic mice when metallothionein is overexpressed in cardiac myocytes","volume":"296","author":"Velic","year":"2013","journal-title":"Anat Rec (Hoboken)"},{"key":"B52","article-title":"Diabetic cardiomyopathy: from pathophysiology to treatment","volume":"55","author":"Trachanas","year":"2014","journal-title":"Hellenic J Cardiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14388","article-title":"Prediabetes Risk Heart failure: A meta-analysis","volume":"23","author":"Cai","year":"2021","journal-title":"Diabetes Obes Metab."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14074","article-title":"Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes","volume":"22","author":"Birkeland","year":"2020","journal-title":"A large multinational cohort study"},{"key":"B56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1871530311313010006","article-title":"Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach","volume":"13","author":"Dei Cas","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/circulationaha.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjcard.2005.07.111","article-title":"Flow mediated dilatation and cardiac function in type 1 diabetes mellitus","volume":"97","author":"Shivalkar","year":"2006","journal-title":"Am J Cardiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00803.x","article-title":"Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes","volume":"10","author":"Brooks","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European society of cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"9584278","DOI":"10.1155\/2017\/9584278","article-title":"Assessment of diabetic cardiomyopathy by cardiovascular magnetic resonance T1 mapping: Correlation with left-ventricular diastolic dysfunction and diabetic duration","volume":"2017","author":"Shang","year":"2017","journal-title":"Journal of Diabetes Research"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.01.004","article-title":"Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction","volume":"87","author":"Ban","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.14141","article-title":"Role of serum biomarkers in early detection of diabetic cardiomyopathy in the West Virginian population","volume":"13","author":"Shaver","year":"2016","journal-title":"Int J Med Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: Current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-0760(98)00060-0","article-title":"Adrenalectomy and dexamethasone treatment alter the patterns of basal and acute phase response-induced expression of acute phase protein genes in rat liver","volume":"66","author":"Sevaljevi\u0107","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000046897","article-title":"The responses of rat liver glucocorticoid receptors and genes for tyrosine aminotransferase, alpha-2-macroglobulin and gamma-fibrinogen to adrenalectomy-, dexamethasone- and inflammation-induced changes in the levels of glucocorticoids and proinflammatory cytokines","volume":"10","author":"Sevaljevi\u0107","year":"2001","journal-title":"Biol Signals Recept"},{"key":"B68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-8549-4_5","article-title":"Markers Inflammation","volume":"1803","author":"Germolec","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2013.134","article-title":"Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease","volume":"32","author":"Scheuermann","year":"2013","journal-title":"EMBO J"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/srep37354","article-title":"Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes","volume":"6","author":"de Gonzalo-Calvo","year":"2016","journal-title":"Sci Rep"},{"key":"B71","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.1038\/s41598-017-13875-2","article-title":"Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy","volume":"7","author":"Copier","year":"2017","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-019-0918-x","article-title":"Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review","volume":"18","author":"Pordzik","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220801161536","article-title":"The role of miRNAs in metabolic diseases","volume":"30","author":"Macvanin","year":"2022","journal-title":"Curr Med Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3843","article-title":"Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control","volume":"99","author":"Santovito","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3510-2","article-title":"Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies","volume":"58","author":"Zhu","year":"2015","journal-title":"Diabetologia"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1039\/c6mb00596a","article-title":"Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes","volume":"13","author":"Nunez Lopez","year":"2016","journal-title":"Mol Biosyst"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.112.265736","article-title":"Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy","volume":"111","author":"Matkovich","year":"2012","journal-title":"Circ Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12967-015-0672-0","article-title":"Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"13","author":"Fang","year":"2015","journal-title":"J Transl Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.02.05","article-title":"Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction","volume":"7","author":"Zhang","year":"2015","journal-title":"J Thorac Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/1381612822666151112151924","article-title":"The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment","volume":"22","author":"Gholamin","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.088","article-title":"HMGA1 is a novel candidate gene for myocardial infarction susceptibility","volume":"227","author":"De Rosa","year":"2017","journal-title":"Int J Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cbin.10701","article-title":"Long non-coding RNA MALAT1 functions as a mediator in cardioprotective effects of fentanyl in myocardial ischemia-reperfusion injury","volume":"41","author":"Zhao","year":"2017","journal-title":"Cell Biol Int"},{"key":"B83","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41419-020-2316-4","article-title":"High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME\u00ae trial","volume":"37","author":"Fitchett","year":"2016","journal-title":"Eur Heart J"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.05.014","article-title":"Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice","volume":"715","author":"Tahara","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"B88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbs075","article-title":"Identifying miRNAs, targets and functions","volume":"15","author":"Liu","year":"2014","journal-title":"Brief Bioinform"},{"key":"B93","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct Target Ther"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2016.02.004","article-title":"MicroRNA: A new therapeutic strategy for cardiovascular diseases","volume":"26","author":"Samanta","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.33696\/diabetes.1.003","article-title":"The profiling and role of miRNAs in diabetes mellitus","volume":"1","author":"Kim","year":"2019","journal-title":"J Diabetes Clin Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.736323","article-title":"MicroRNA as an important target for anticancer drug development","volume":"12","author":"Fu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"9007","DOI":"10.1038\/s41598-021-88617-6","article-title":"The microRNA analysis portal is a next-generation tool for exploring and analyzing miRNA-focused data in the literature","volume":"11","author":"Pirr\u00f2","year":"2021","journal-title":"Sci Rep"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/jocs.15329","article-title":"Micro-RNA gene expressions during cardiopulmonary bypass","volume":"36","author":"T\u00fclay Ayd\u0131n","year":"2021","journal-title":"Journal of Cardiac Surgery"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2931","article-title":"From guide to target: molecular insights into eukaryotic RNA-interference machinery","volume":"22","author":"Ipsaro","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.09.004","article-title":"Pairing beyond the seed supports MicroRNA targeting specificity","volume":"64","author":"Broughton","year":"2016","journal-title":"Mol Cell"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0803230105","article-title":"A search for conserved sequences in coding regions reveals that the let-7 microRNA targets dicer within its coding sequence","volume":"105","author":"Forman","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1261\/rna.045757.114","article-title":"MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells","volume":"20","author":"Zhou","year":"2014","journal-title":"Rna"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1261\/rna.045633.114","article-title":"Cellular microRNAs up-regulate transcription via interaction with promoter TATA-box motifs","volume":"20","author":"Zhang","year":"2014","journal-title":"Rna"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.538","article-title":"SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco\/endoplasmic reticulum Ca(2+)-ATPase 2","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3390\/ijms20133264","article-title":"Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy","volume":"20","author":"Evangelista","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"8887","DOI":"10.1038\/s41598-019-43793-4","article-title":"Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes","volume":"9","author":"Mononen","year":"2019","journal-title":"Sci Rep"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00528","article-title":"MicroRNA-1281 as a novel circulating biomarker in patients with diabetic retinopathy","volume":"11","author":"Greco","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/cells10040742","article-title":"High glucose treatment limits drosha protein expression and alters AngiomiR maturation in microvascular primary endothelial cells via an Mdm2-dependent mechanism","volume":"10","author":"Lam","year":"2021"},{"key":"B112","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12013-013-9679-4","article-title":"Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+\/- akita hearts","volume":"68","author":"Chavali","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00137.2012","article-title":"miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart","volume":"303","author":"Baseler","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/187153009787582397","article-title":"p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus","volume":"9","author":"Liu","year":"2009","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.06.023","article-title":"p38\u03b1 mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitate","volume":"450","author":"Oh","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B116","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12872-015-0030-4","article-title":"Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats","volume":"15","author":"Liang","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0238","article-title":"MK2 deletion in mice prevents diabetes-induced perturbations in lipid metabolism and cardiac dysfunction","volume":"65","author":"Ruiz","year":"2016","journal-title":"Diabetes"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0385-2","article-title":"Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus","volume":"49","author":"Westermann","year":"2006","journal-title":"Diabetologia"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0719-8","article-title":"Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy","volume":"50","author":"Van Linthout","year":"2007","journal-title":"Diabetologia"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.04.034","article-title":"MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy","volume":"179","author":"Shen","year":"2011","journal-title":"Am J Pathol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","article-title":"miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy","volume":"417","author":"Raut","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0811-7","article-title":"MiR-30c\/PGC-1\u03b2 protects against diabetic cardiomyopathy via PPAR\u03b1","volume":"18","author":"Yin","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.143995","article-title":"Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K\/Akt signaling pathway via PIK3CA","volume":"715","author":"Yang","year":"2019","journal-title":"Gene"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2005.10.004","article-title":"Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling","volume":"39","author":"Kirchhefer","year":"2006","journal-title":"Cell Calcium"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2008.01.012","article-title":"Overexpression of junctate induces cardiac hypertrophy and arrhythmia via altered calcium handling","volume":"44","author":"Hong","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-013-9672-y","article-title":"Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1","volume":"67","author":"Yildirim","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv599","article-title":"MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart","volume":"37","author":"Costantino","year":"2016","journal-title":"Eur Heart J"},{"key":"B128","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31083\/j.rcm.2020.01.577","article-title":"Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease","volume":"21","author":"Song","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"9167450","DOI":"10.1155\/2017\/9167450","article-title":"miR-503 is involved in the protective effect of phase II enzyme inducer (CPDT) in diabetic cardiomyopathy via Nrf2\/ARE signaling pathway","volume":"2017","author":"Miao","year":"2017","journal-title":"BioMed Research International"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.166","article-title":"Viral vector-based targeting of miR-21 in cardiac nonmyocyte cells reduces pathologic remodeling of the heart","volume":"24","author":"Ramanujam","year":"2016","journal-title":"Mol Ther"},{"key":"B131","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-018-0767-z","article-title":"MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin","volume":"17","author":"Dai","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.07.019","article-title":"LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21\/PPARa signaling","volume":"1864","author":"Gao","year":"2018","journal-title":"Biochim Biophys Acta (BBA)-Molecular Basis Dis"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmt067","article-title":"MicroRNA-150 aggravates H2O2-induced cardiac myocyte injury by down-regulating c-myb gene","volume":"45","author":"Li","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/srep36340","article-title":"lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.03.005","article-title":"Mir30c is involved in diabetic cardiomyopathy through regulation of cardiac autophagy via BECN1","volume":"7","author":"Chen","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.11.058","article-title":"MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension","volume":"109","author":"Li","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29386","article-title":"Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts","volume":"235","author":"Che","year":"2020","journal-title":"Journal of Cellular Physiology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2017-0024","article-title":"Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT","volume":"9","author":"Coto","year":"2017","journal-title":"Epigenomics"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.08.005","article-title":"Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia\/reperfusion injury following acute myocardial infarction","volume":"491","author":"Li","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13637","article-title":"LncRNA H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy","volume":"8","author":"Zhuo","year":"2017","journal-title":"Oncotarget"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12576","article-title":"Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells","volume":"19","author":"Puthanveetil","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s203151","article-title":"Downregulation of MALAT1 alleviates saturated fatty acid-induced myocardial inflammatory injury via the miR-26a\/HMGB1\/TLR4\/NF-\u03baB axis","volume":"12","author":"Jia","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autneu.2016.07.012","article-title":"LncRNA NONRATT021972 siRNA rescued decreased heart rate variability in diabetic rats in superior cervical ganglia","volume":"201","author":"Xu","year":"2016","journal-title":"Auton Neurosci"},{"key":"B144","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-019-0814-4","article-title":"Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium","volume":"18","author":"Rawal","year":"2019","journal-title":"Cardiovascular Diabetology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29134","article-title":"RNA-Seq analysis and functional characterization revealed lncRNA NONRATT007560.2 regulated cardiomyocytes oxidative stress and apoptosis induced by high glucose","volume":"120","author":"Yu","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6755","article-title":"LncRNA HOTAIR improves diabetic cardiomyopathy by increasing viability of cardiomyocytes through activation of the PI3K\/Akt pathway","volume":"16","author":"Qi","year":"2018","journal-title":"Exp Ther Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27296","article-title":"LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy","volume":"234","author":"Gao","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.02.050","article-title":"CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC","volume":"419","author":"Congrains","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29162","article-title":"Interfering with long chain noncoding RNA ANRIL expression reduces heart failure in rats with diabetes by inhibiting myocardial oxidative stress","volume":"120","author":"Dai","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8227(09)70002-6","article-title":"Hypothesis: the \"metabolic memory\", the new challenge of diabetes","author":"Ceriello","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00382","article-title":"Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases","volume":"10","author":"da Costa","year":"2019","journal-title":"Front Pharmacol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1172\/jci88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J Clin Invest"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0457ED","article-title":"Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury","volume":"182","author":"Reddy","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/641087","article-title":"PPAR\u03b3 and oxidative stress: Con(\u03b2) catenating NRF2 and FOXO","volume":"2012","author":"Polvani","year":"2012","journal-title":"PPAR Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.06.002","article-title":"Hepatic hypoxia-inducible factors inhibit PPAR\u03b1 expression to exacerbate acetaminophen induced oxidative stress and hepatotoxicity","volume":"110","author":"Li","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/1755-5922.12113","article-title":"miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy","volume":"33","author":"Raut","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4283","article-title":"Genome-wide screening for functional long noncoding RNAs in human cells by Cas9 targeting of splice sites","volume":"36","author":"Liu","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.yjmcc.2009.01.008","article-title":"MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4","volume":"47","author":"Cheng","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12318","article-title":"Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via sirt 1","volume":"36","author":"Tang","year":"2018","journal-title":"Cardiovasc Ther"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int J Biol Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-377648","article-title":"Platelet TGF-\u03b21 contributions to plasma TGF-\u03b21, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload","volume":"119","author":"Meyer","year":"2012","journal-title":"Blood"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.120.15016","article-title":"Platelets promote ang II (Angiotensin II)-induced atrial fibrillation by releasing TGF-\u03b21 (Transforming growth factor-\u03b21) and interacting with fibroblasts","volume":"76","author":"Liu","year":"2020","journal-title":"Hypertension"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.171","article-title":"TGF-\u03b2 and NF-\u03baB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers","volume":"32","author":"Freudlsperger","year":"2013","journal-title":"Oncogene"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2015.11.001","article-title":"MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28\/B7 costimulatory pathway","volume":"172","author":"Sang","year":"2016","journal-title":"Immunol Lett"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.060","article-title":"miR-150 regulates memory CD8 T cell differentiation via c-myb","volume":"20","author":"Chen","year":"2017","journal-title":"Cell Rep"},{"key":"B167","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/bfgp\/elv022","article-title":"Advances in long noncoding RNAs: identification, structure prediction and function annotation","volume":"15","author":"Guo","year":"2016","journal-title":"Brief Funct Genomics"},{"key":"B168","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40781-018-0183-7","article-title":"Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review","volume":"60","author":"Dhanoa","year":"2018","journal-title":"Journal of Animal Science and Technology"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1101\/gad.17446611","article-title":"Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses","volume":"25","author":"Cabili","year":"2011","journal-title":"Genes Dev"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/ng.848","article-title":"Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters","volume":"43","author":"Hung","year":"2011","journal-title":"Nat Genet"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.03.021","article-title":"Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a","volume":"38","author":"Yap","year":"2010","journal-title":"Mol Cell"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2521","article-title":"The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r","volume":"14","author":"Keniry","year":"2012","journal-title":"Nat Cell Biol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nsmb.2764","article-title":"Topological organization of multichromosomal regions by the long intergenic noncoding RNA firre","volume":"21","author":"Hacisuleyman","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-0674(03)00041-3","article-title":"Epigenetic gene regulation by noncoding RNAs","volume":"15","author":"Andersen","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.08.011","article-title":"The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation","volume":"39","author":"Tripathi","year":"2010","journal-title":"Mol Cell"},{"key":"B177","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/10409238.2013.844092","article-title":"Gene regulation by non-coding RNAs","volume":"49","author":"Patil","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-051410-092902","article-title":"Genome regulation by long noncoding RNAs","volume":"81","author":"Rinn","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002803","article-title":"Poly a- transcripts expressed in HeLa cells","volume":"3","author":"Wu","year":"2008","journal-title":"PloS One"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0311-8","article-title":"Cellular functions of long noncoding RNAs","volume":"21","author":"Yao","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2018.1546896","article-title":"LncRNA TINCR is downregulated in diabetic cardiomyopathy and relates to cardiomyocyte apoptosis","volume":"52","author":"Chen","year":"2018","journal-title":"Scand Cardiovasc J"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1159\/000494576","article-title":"LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy","volume":"50","author":"Yang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7362","article-title":"Downregulation of lncRNA-SRA participates in the development of cardiovascular disease in type II diabetic patients","volume":"17","author":"Ren","year":"2019","journal-title":"Exp Ther Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1159\/000485588","article-title":"Circulating long noncoding RNA HOTAIR is an essential mediator of acute myocardial infarction","volume":"44","author":"Gao","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.117.305962","article-title":"MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction","volume":"117","author":"Yang","year":"2015","journal-title":"Circ Res"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2016.02.011","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction","volume":"1861","author":"Zlobine","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1097\/jcma.0000000000000182","article-title":"Expression and function of lncRNA ANRIL in a mouse model of acute myocardial infarction combined with type 2 diabetes mellitus","volume":"82","author":"Zhang","year":"2019","journal-title":"J Chin Med Assoc"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-42059-2_12","article-title":"Non-coding RNAs: Therapeutic strategies and delivery systems","volume":"937","author":"Ling","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.119.315856","article-title":"Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ Res"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201100899","article-title":"Development of microRNA therapeutics is coming of age","volume":"6","author":"van Rooij","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Invest New Drugs"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"British Journal of Cancer"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2016.0656","article-title":"Molecular mechanisms of antisense oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8651-4_26","article-title":"Pre-mRNA splicing modulation by antisense oligonucleotides","volume":"1828","author":"Singh","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nature Reviews Drug Discovery"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with 'antagomirs'","volume":"438","author":"Kr\u00fctzfeldt","year":"2005","journal-title":"Nature"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt852","article-title":"Miravirsen (SPC3649) can inhibit the biogenesis of miR-122","volume":"42","author":"Gebert","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"key":"B201","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.3390\/molecules25204659","article-title":"Modified nucleic acids: Expanding the capabilities of functional oligonucleotides","volume":"25","author":"Ochoa","year":"2020"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.112.267443","article-title":"MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis","volume":"111","author":"Corsten","year":"2012","journal-title":"Circ Res"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s138400","article-title":"Gold nanoparticle-based miR155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model","volume":"12","author":"Jia","year":"2017","journal-title":"Int J Nanomed"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.114.000946","article-title":"Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling","volume":"3","author":"Bellera","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1038\/nature02870","article-title":"Unlocking the potential of the human genome with RNA interference","volume":"431","author":"Hannon","year":"2004","journal-title":"Nature"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic targeting of long non-coding RNAs in cancer","volume":"24","author":"Arun","year":"2018","journal-title":"Trends Mol Med"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR technologies in research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat Biotechnol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1038\/srep22312","article-title":"CRISPR\/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14930","article-title":"microRNA-210-3p depletion by CRISPR\/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma","volume":"8","author":"Yoshino","year":"2017","journal-title":"Oncotarget"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.01.019","article-title":"Hacking the cancer genome: Profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening","volume":"35","author":"Esposito","year":"2019","journal-title":"Cancer Cell"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0428-0","article-title":"Fitness effects of CRISPR\/Cas9-targeting of long noncoding RNA genes","volume":"38","author":"Horlbeck","year":"2020","journal-title":"Nature Biotechnology"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/cancers12061458","article-title":"Challenges and strategies in ascribing functions to long noncoding RNAs","volume":"12","author":"Zhao","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1124613\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T06:43:41Z","timestamp":1678085021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1124613\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":214,"alternative-id":["10.3389\/fendo.2023.1124613"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1124613","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"article-number":"1124613"}}